Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Tumbleweed67on Apr 18, 2011 11:24pm
468 Views
Post# 18450648

RE: RE: RE: US Army

RE: RE: RE: US ArmyNot that I haven't been paying attention, but what is it we expect/hope to gain from the DoD?
Obviously, their involvement could go a long way to returning some legitimacy to SCT in many investors minds, and hopefully translate into a better SP. But what is at stake monetarily? Are we talking 1/2 a million dollars? $1M? $5M? Full funding of the TBI trials?
Anyone have any idea what might have been proposed?
And what if the proposal is denied...where will the SP go then?
We seem to be hanging by a thread here these days.

TW
Bullboard Posts